The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60 ...

The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...

The new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...

The expanded recommendation is good news for Moderna, Pfizer, and GSK, which all sell RSV vaccines for older adults. Moderna ...

Shares of Moderna MRNA rose nearly 6% yesterday after the U.S. Centers for Disease Control and Prevention (“CDC”) adopted new ...

The Centers for Disease Control and Prevention's vaccine advisory committee wrapped up the first day of its meeting since ...

“These vaccines provide an opportunity to help protect older adults against severe RSV illness at a time when multiple respiratory infections are likely to circulate,” the CDC said in a statement.

The vote to recommend the vaccine was 11 to 1. The specific question advisers voted on was: “Maternal RSV vaccine is recommended for pregnant people during 32 through 36 weeks gestation, using ...

The first vaccines to guard against the respiratory illness RSV will soon be available for some older adults, ages 60 and over, after the CDC formally backed recommendations for the shots.

The U.S. Centers for Disease Control and Prevention has accepted recommendations made by an advisory panel in April on the ...